Holen Sie sich die Stockscreener-App
7.59
4.98%
0.36
Handel nachbörslich:
7.58
-0.010
-0.13%
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks: Hedge Funds Pull Back and Other Important Updates - TradingView
From Promise to Peril: The Downfall of Ginkgo Bioworks - TradingView
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Top 5 Synthetic Biology Public Companies (June 2025) - Securities.io
Northern Trust Corp Buys 9,791 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
(DNA) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Millennium Management LLC Has $6.58 Million Stake in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World
Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care - Quantisnow
Ginkgo Bioworks: Cost-Cutting Efforts Aren't Enough (NYSE:DNA) - Seeking Alpha
Major Moves And Shakes In Health Care Sector - Finimize
Sector Update: Health Care - marketscreener.com
Ginkgo Bioworks announces CFO transition - MSN
Ginkgo Bioworks (DNA) Announces CFO Transition - GuruFocus
Ginkgo Bioworks CFO Mark Dmytruk to Resign, Steven Coen Appointed as New Finance Chief - marketscreener.com
Ginkgo Bioworks Announces Appointment Of Steven Coen As Chief Financial Officer - marketscreener.com
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bi - GuruFocus
Charles River Laboratories (CRL): Leadership Change at Ginkgo Bioworks | CRL Stock News - GuruFocus
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer - StreetInsider
Ginkgo Bioworks Promotes 30-Year Finance Expert to CFO Role, Maintains 2026 EBITDA Target - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) is a favorite amongst institutional investors who own 56% - Yahoo Finance
When the Price of (DNA) Talks, People Listen - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Moves -1.94%: What You Should Know - MSN
Twist Bioscience and Ginkgo Bioworks update 2022 partnership - MSN
Ginkgo outlines $250M cost reduction target and tools expansion in Q1 2025 update - MSN
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) First-Quarter Results: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Acquired by Barclays PLC - Defense World
Ginkgo Bioworks Holdings, Inc. (DNA): Among Nicholas J. Pritzker’s Stock Picks with Huge Upside Potential - MSN
Billionaire Nicholas J. Pritzker’s 8 Stocks with Huge Upside Potential - Insider Monkey
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE: DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Twist Bioscience and Ginkgo Bioworks Revise Collaboration - Stock Titan
GINKGO BIOWORKS HOLDINGS, INC. F/K/A SOARING EAGLE ACQUISITION CORP. (NYSE:DNA, SRNG) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Cla - ACCESS Newswire
Scientists Discover Bacteria That Breathes Electricity — A Game-Changer for Green Energy - Securities.io
Twist Bioscience and Ginkgo Bioworks update DNA supply deal - Investing.com
Ginkgo Bioworks Earnings Call: Optimism Amid Challenges - TipRanks
How to Take Advantage of moves in (DNA) - news.stocktradersdaily.com
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q1 2025 Earnings Call Transcript - Insider Monkey
Ginkgo Bioworks Q1 2025 Earnings Call Transcript - MarketBeat
Ginkgo Bioworks Holdings Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Ginkgo Bioworks Holdings Inc (DNA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Ginkgo Bioworks Reports Strong Q1 2025 Growth - TipRanks
Ginkgo Bioworks Q1 2025 slides: Revenue grows 27% as cost-cutting advances - Investing.com Canada
Earnings call transcript: Ginkgo Bioworks’ Q1 2025 revenue rises, stock slips - Investing.com Canada
Ginkgo Bioworks (DNA) Surpasses Revenue Expectations with Strong Q1 Performance | DNA Stock News - GuruFocus
Ginkgo Bioworks (DNA) Anticipates Volatility Ahead of Earnings R - GuruFocus
Ginkgo Bioworks Reports First Quarter 2025 Financial Results - The Malaysian Reserve
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
Ginkgo (DNA) Updates Revenue Projections for FY25 | DNA Stock News - GuruFocus
Ginkgo Bioworks Holdings, Inc. SEC 10-Q Report - TradingView
Ginkgo Bioworks Q1 2025 Financial Results - TradingView
Ginkgo Bioworks Reports First Quarter 2025 Financial Results – Company Announcement - Financial Times
Ginkgo Bioworks Holdings Inc expected to post a loss of $1.77 a shareEarnings Preview - TradingView
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports - Barchart.com
0.00%
2.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):